Optimization of Caco-2 and HT29 co-culture in vitro cell models for permeability studies

International Journal of Food Sciences and Nutrition

Volumn 66, Issue 6, 2015, Pages 680-685

  Pan, Fengguang ^a   Han, Lu ^a   Zhang, Yan ^a   Yu, Yiding ^a   Liu, Jingbo ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Cell seeding ratio; Co culture; Gene expression; Monolayer; Optimization

Indexed keywords

ALCIAN BLUE; ALKALINE PHOSPHATASE; ALPI PROTEIN, HUMAN; COLORING AGENT; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MUC5AC PROTEIN, HUMAN; MUCIN 5AC;

CACO 2 CELL LINE; COCULTURE; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; HUMAN; IMPEDANCE; METABOLISM; MUCUS; PERMEABILITY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STAINING;

ALCIAN BLUE; ALKALINE PHOSPHATASE; CACO-2 CELLS; COCULTURE TECHNIQUES; COLORING AGENTS; ELECTRIC IMPEDANCE; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HT29 CELLS; HUMANS; MUCIN 5AC; MUCUS; PERMEABILITY; REAL-TIME POLYMERASE CHAIN REACTION; STAINING AND LABELING;

EID: 84958256830     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2015.1077792     Document Type: Article

References (38)

1. Agarwal S, Jain R, Pal D, Mitra AK. 2007. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies. Int J Pharm 332:147-152.
2. Antunes F, Andrade F, Ferreira D, Nielsen HM, Sarmento B. 2013. Models to predict intestinal absorption of therapeutic peptides and proteins. Curr Drug Metab 14:4-20.
3. Araujo F, Sarmento B. 2013. Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies. Int J Pharm 458:128-134.
4. Artursson P, Palm K, Luthman K. 2012. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 64:280-289.
5. Balimane PV, Chong S. 2005. Cell culture-based models for intestinal permeability: a critique. Drug Discov Today 10:335-343.
6. Baumgart DC, Dignass AU. 2002. Intestinal barrier function. Curr Opin Clin Nutr Metab Care 5:685-694.
7. Beduneau A, Tempesta C, Fimbel S, Pellequer Y, Jannin V, Demarne F, Lamprecht A. 2014. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure. Eur J Pharm Biopharm 87:290-298.
8. Behrens I, Stenberg P, Artursson P, Kissel T. 2001. Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells. Pharm Res 18:1138-1145.
9. Calatayud M, Vazquez M, Devesa V, Velez D. 2012. In vitro study of intestinal transport of inorganic and methylated arsenic species by Caco-2/HT29-MTX cocultures. Chem Res Toxicol 25:2654-2662.
10. Carr DA, Peppas NA. 2010. Assessment of poly(methacrylic acid-co-N-vinyl pyrrolidone) as a carrier for the oral delivery of therapeutic proteins using Caco-2 and HT29-MTX cell lines. J Biomed Mater Res A 92A:504-512.
11. Chen XM, Elisia I, Kitts DD. 2010. Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design. J Pharmacol Toxicol Methods 61:334-342.
12. Ding L, Zhang Y, Jiang YQ, Wang LY, Liu BQ, Liu JB. 2014. Transport of egg white ACE-inhibitory peptide, Gln-Ile-Gly-Leu-Phe, in human intestinal Caco-2 cell monolayers with cytoprotective effect. J Agric Food Chem 62:3177-3182.
13. Gouyer V, Wiede A, Buisine MP, Dekeyser S, Moreau O, Lesuffleur T, Hoffmann W, Huet G. 2001. Specific secretion of gel-forming mucins and TFF peptides in HT-29 cells of mucin-secreting phenotype. Biochim Biophys Acta Mol Cell Res 1539:71-84.
14. Han LN, Zhao YF, Yin LF, Li RM, Liang Y, Huang H, Pan SR, et al. 2012. Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular delivery. AAPS PharmSciTech 13:836-845.
15. Hilgendorf C, Spahn-Langguth H, Regardh CG, Lipka E, Amidon GL, Langguth P. 2000. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci 89:63-75.
16. Huber R, Kunisch E, Gluck B, Egerer R, Sickinger S, Kinne RW. 2003. Comparison of conventional and real-time RT-PCR for the quantitation of jun proto-oncogene mRNA and analysis of junB mRNA expression in synovial membranes and isolated synovial fibroblasts from rheumatoid arthritis patients. Z Rheumatol 62:378-389.
17. Kim GH, Klotchkova TA, Lee BC, Kim SH. 2001. FITC-phalloidin staining of F-actin in Aglaothamnion oosumiense and Griffithsia japonica (Rhodophyta). Bot Marina 44:501-508.
18. Komatsu H, Tsunoda T, Inui A, Sogo T, Fujisawa T, Imura M, Tateno A. 2013. Successful use of saliva without DNA extraction for detection of macrolide-resistant Mycoplasma pneumoniae DNA in children using LNA probe-based real-time PCR. J Infect Chemother 19:1087-1092.
19. Le Ferrec E, Chesne C, Artusson P, Brayden D, Fabre G, Gires P, Guillou F, et al. 2001. In vitro models of the intestinal barrier - the report and recommendations of ECVAM Workshop 46. ATLA-Altern Lab Anim 29:649-668.
20. Leonard F, Collnot EM, Lehr CM. 2010. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. Mol Pharm 7:2103-2119.
21. Li N, Wang DD, Sui ZG, Qi XY, Ji LY, Wang XL, Yang L. 2013. Development of an improved three-dimensional in vitro intestinal mucosa model for drug absorption evaluation. Tissue Eng C Methods 19:708-719.
22. Lin XN, Skolnik S, Chen XH, Wang JL. 2011. Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model. Drug Metab Dispos 39:265-274.
23. Mahler GJ, Shuler ML, Glahn RP. 2009. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. J Nutr Biochem 20:494-502.
24. Martinez-Augustin O, Rivero-Gutierrez B, Mascaraque C, de Medina FS. 2014. Food derived bioactive peptides and intestinal barrier function. Int J Mol Sci 15:22857-22873.
25. Matsumoto H, Erickson RH, Gum JR, Yoshioka M, Gum E, Kim YS. 1990. Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2. Gastroenterology 98(Pt 1):1199-1207.
26. Menon RM, Barr WH. 2003. Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified ussing chambers. Biopharm Drug Dispos 24:299-308.
27. Nollevaux G, Deville C, El Moualij B, Zorzi W, Deloyer P, Schneider YJ, Peulen O, Dandrifosse G. 2006. Development of a serum-free coculture of human intestinal epithelium cell-lines (Caco-2/HT29-5M21). BMC Cell Biol 7:11.
28. Pontier C, Pachot J, Botham R, Lenfant B, Arnaud P. 2001. HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. J Pharm Sci 90:1608-1619.
29. Rocha RA, Velez D, Devesa V. 2012. In vitro evaluation of intestinal fluoride absorption using different cell models. Toxicol Lett 210:311-317.
30. Sambuy Y, Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. 2005. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21:1-26.
31. Silva CM, Veiga F, Ribeiro AJ, Zerrouk N, Arnaud P. 2006. Effect of chitosan-coated alginate microspheres on the permeability of Caco-2 cell monolayers. Drug Dev Ind Pharm 32:1079-1088.
32. Smetanova L, Stetinova V, Svoboda Z, Kvetina J. 2011. Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver. Acta Med 54:3-8.
33. Stellwagen NC. 2009. Electrophoresis of DNA in agarose gels, polyacrylamide gels and in free solution. Electrophoresis 30:S188-S195.
34. Tavelin S, Taipalensuu J, Soderberg L, Morrison R, Chong SH, Artursson P. 2003. Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers. Pharm Res 20:397-405.
35. Walter E, Janich S, Roessler BJ, Hilfinger JM, Amidon GL. 1996. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci 85:1070-1076.
36. Wan LY, Allen KJ, Turner PC, El-Nezami H. 2014. Modulation of mucin mRNA (MUC5AC and MUC5B) expression and protein production and secretion in Caco-2/HT29-MTX co-cultures following exposure to individual and combined Fusarium mycotoxins. Toxicol Sci 139:83-98.
37. Wood KM, Stone GM, Peppas NA. 2010. The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models. Acta Biomater 6:48-56.
38. Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H. 2000. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci 10:195-204.